During this webinar, we look specifically at Solid forms in drug discovery and development, which remains an area of intense interest to the pharmaceutical industry and consequently to the CROs supporting medicinal chemistry projects . Understanding and control of crystalline solid form is fundamental to both efficient large scale synthesis and the creation of stable, consistent and effective drug formulations.
Key Learning Objectives:
The importance of solid form in drug discovery and how discovery and medicinal chemists can collaborate most effectively with pharmaceutical scientists and structural informatics experts to optimise drug performance.
- The impact of uncontrolled crystal form polymorphism and the effect it can have on pharmaceutical drug product robustness.
- How the latest developments in structural informatics can provide confidence and predictability in polymorph studies.
- This webinar will discuss how the skills and knowledge of discovery chemists and pharmaceutical scientists can be applied most effectively to solve solid form problems and how modern structural informatics can give new insights into polymorph studies.
This webinar has finished, please click here for free access to the recorded video.
Looking for another webinar?
- Antibody Drug Conjugates
- Stable-Isotope Labelled Compounds: Synthesis and Applications
- Early Developments in Drug Discovery Science – Understanding Compound Liability/Toxicity in Early Discovery
- Solid Forms in Drug Discovery
- Modified Sugars to Stabilise Nucleic Acid Duplexes for Therapeutic Applications
- Sugar Modified Nucleosides and Nucleotides: The Synthesis of Anti-Viral Drugs